-b-D-glucoside
Catalog Number 850510 Physical state Powder
Purity > 99%; contains 2% a isomer Transition temp. No data
CAS 69984-73-2 CMC 6.5 mM
Synonyms n-nonyl-ß-D-glucoside; nonyl glucoside; NG;
et al., Cancer Res., 51, 6019-6024
(1991).
2. Park, Y.S., et al., Cancer Res., 54, 2213-2217
(1994).
3. Scalia, R. et al., J. Leukoc. Biol., 59, 317-324
(1996).
4. Kimura, S., et al., Biochem
Serum-free
culture of Pasteurella haemolytica optimized for
leukotoxin production. Am. J. Vet. Res., 59(7),
851-855 (1998).
GCY/NSB 1/03
Sigma brand products are sold through Sigma-Aldrich
Pasteurella haemolytica optimized for
leukotoxin production. Am. J. Vet. Res., 59(7),
851-855 (1998).
GCY/NSB 2/03
Sigma brand products are sold through Sigma-Aldrich, Inc.
Sigma-Aldrich
temperature-dependent phase behavior of monoolein-detergnet mixtures. Acta Crystallogr D Biol Crystal-
logr. 59(Pt 2): 239-46
Related products: Detergents
MSDS: Available at www.avantilipids.com for Product Number
Serum-free
culture of Pasteurella haemolytica optimized for
leukotoxin production. Am. J. Vet. Res., 59(7),
851-855 (1998).
GCY/NSB 3/03
Sigma brand products are sold through Sigma-Aldrich
and its metabolites in human urine in the
presence of ethyl alcohol." J. Anal. Toxicol. 3, 59-63 (1979).
2. Lukaszewski, T., Jeffery, W.K. "Impurities and artifacts of illicit cocaine." J. Forensic. Sci
References
2. Collman, M., et al., Proc. Natl. Acad. Sci.
USA, 71, 4404 (1974).
3. Coleman, M., et al., Cancer Res., 36, 120
(1976).
4. Greenwood, M., et al., J. Clin. Inv., 59, 889
(1977).
Washington, D.C.), pp. 99-109 (1986).
4. Mlinar, Diana, "The Role of Trappin-2 and RANTES
in Mediating Resistance to HIV-1 Infection".
University of Manitoba, M.Sc. thesis, p. 59
(2008).
5. Hou
points can be customized.
• Duration (HH:MM:SS) up to 99:99:99
• LED intensity (%) – 1% to 100%
• Post-cool duration (MM:SS) - 00:00 to 59:59
• Stir(rpm) – 100 to 2000
volume of cocktail required.
References
1. Umezawa, H., Ann. Rev. Microbiol., 36, 75-99
(1982).
2. Aoyagi, T. et al., Biochem. Int., 9(4), 405-411
(1984).
3. Aoyagi, T., and Umezawa, H.
and negatively
charged liposomes on skin permeation of drugs. J.
Drug Targeting, 9, 49-59 (2001).
2. Lasic, D.D., Liposomes from Physics to Applications,
Elsevier, Netherlands (1993).
3. New